Detalles de la búsqueda
1.
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
N Engl J Med
; 385(16): 1451-1461, 2021 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34449189
2.
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
N Engl J Med
; 383(15): 1413-1424, 2020 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32865377
3.
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.
Eur Heart J
; 43(5): 416-426, 2022 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34878502
4.
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced.
Circulation
; 143(4): 310-321, 2021 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33095032
5.
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial.
Circulation
; 144(16): 1284-1294, 2021 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34459213
6.
Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial.
Eur Heart J
; 42(43): 4442-4451, 2021 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34184057
7.
Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial.
Eur Heart J
; 42(6): 671-680, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33459776
8.
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial.
JACC Heart Fail
; 11(4): 407-417, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36881400
9.
Dabigatran versus warfarin in the treatment of acute venous thromboembolism.
N Engl J Med
; 361(24): 2342-52, 2009 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19966341
10.
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved.
Nat Med
; 28(12): 2512-2520, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36471037
11.
Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial.
J Am Coll Cardiol
; 78(13): 1321-1332, 2021 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34556318
12.
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial.
Eur J Heart Fail
; 22(12): 2383-2392, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33251670
13.
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.
J Arthroplasty
; 24(1): 1-9, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18534438
14.
Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial.
Eur J Heart Fail
; 21(10): 1279-1287, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31523904
15.
Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial.
Eur J Heart Fail
; 21(10): 1270-1278, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31584231
16.
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.
Lancet
; 370(9591): 949-56, 2007 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17869635
17.
Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
J Am Coll Cardiol
; 43(9): 1698-705, 2004 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-15120833
18.
A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
Thromb Haemost
; 114(6): 1290-8, 2015 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-26446456
19.
Characteristics of patients with non-valvular atrial fibrillation using dabigatran or warfarin in the US.
Curr Med Res Opin
; 30(5): 795-804, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24392958
20.
Evaluation of the acute coronary syndrome safety profile of dabigatran etexilate in patients undergoing major orthopedic surgery: findings from four Phase 3 trials.
Thromb Res
; 130(3): 396-402, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22704461